Current recommendations suggest that women stop GLP-1 medications when planning a pregnancy or as soon as they find out they are pregnant and not to resume until they have finished breastfeeding
This article examines nausea rates across different weight loss injections, explores why gastrointestinal side effects occur, and provides evidence-based strategies for managing symptoms during treatment
the nutritionist works closely with the patient to select the most appropriate dietary approachwhether it is the MD, the KD, or another planbased on the patients needs and tolerance
Richards P, Parker HE, Adriaenssens AE, Hodgson JM, Cork SC, Trapp S, et al
Efficacy of semaglutide in subjects with obesity and prediabetes: Sustained effects after 2 years of treatment
Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis